Offender Pharmaceutical Services

The Department of Behavioral Health and Developmental Disabilities (DBHDD) in Georgia is seeking qualified pharmaceutical service providers for the Jail Restoration Center, a facility with a maximum capacity of 31 beds. This procurement opportunity requires a comprehensive pharmaceutical services program that includes general and specialized pharmacy services for inmate populations. The contractor must provide an all-inclusive pharmaceutical solution encompassing over-the-counter medications, IV medications, and vaccines, with strict compliance to all federal, state, and local regulatory requirements. The contract opportunity, identified by the number 6846bbd9ddc05b5b1c005f62, was posted on June 6, 2025, with proposals due by June 27, 2025. Potential suppliers must demonstrate full capability to address pharmacy service requirements for DBHDD, ensuring complete adherence to governing laws, statutes, rules, and regulations. The procurement appears to prioritize suppliers with extensive experience in correctional healthcare pharmaceutical services and the ability to manage a comprehensive medication management program.

While specific set-aside designations are not explicitly detailed in the available information, the contract seems open to qualified pharmaceutical service providers with demonstrated expertise in correctional healthcare settings. No incumbent vendors are mentioned in the current documentation. The procurement does not specify a precise budget range or award value, though the limited 31-bed capacity suggests a potentially moderate-scale contract. Interested suppliers will likely need to demonstrate robust pharmaceutical distribution capabilities, regulatory compliance, medication tracking systems, and the ability to serve a specialized correctional healthcare environment. The contract appears designed to ensure consistent, high-quality pharmaceutical services for the Jail Restoration Center's inmate population, with a focus on comprehensive medication management and regulatory compliance. Potential bidders should be prepared to provide detailed evidence of their capability to meet the stringent requirements of this specialized pharmaceutical service contract.